Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.580
+0.0702.79%
Volume:540.00K
Turnover:1.39M
Market Cap:1.42B
PE:-6.75
High:2.620
Open:2.510
Low:2.510
Close:2.510
52wk High:4.600
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:1.40
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.382
ROE:-12.02%
ROA:-8.17%
PB:0.78
PE(LYR):-6.75
PS:38.35

Loading ...

Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital

Bulletin Express
·
Jun 30

Zhaoke Ophthalmology-B Allocates Approximately HK$229,400 for Share Repurchase on June 30

Stock News
·
Jun 30

Kangda International Environmental Names Liew Fui Kiang Independent Non-executive Director

Reuters
·
Jun 29

Zhaoke Ophthalmology repurchases 1.56 million shares; issued share capital unchanged at 548.75 million

Bulletin Express
·
Jun 29

Zhaoke Ophthalmology buys back 1.30 million shares in June; total share count unchanged at 548.75 million

Bulletin Express
·
Jun 25

Zhaoke Ophthalmology-B Executes Share Buyback on June 23

Stock News
·
Jun 24

Zhaoke Ophthalmology buys back 1.29 million shares, utilises 2.34% of 2026 mandate

Bulletin Express
·
Jun 24

Zhaoke Ophthalmology-B's Four Buybacks Fail to Impress Market; What Could Drive a Rebound from Below Book Value?

Stock News
·
Jun 23

Zhaoke Ophthalmology-B Executes Share Buyback on June 22

Stock News
·
Jun 23

Zhaoke Ophthalmology Reports 1.16 Million-Share Buyback; Issued Share Capital Unchanged

Bulletin Express
·
Jun 23

Zhaoke Ophthalmology files HKEX next-day disclosure return on share repurchase for cancellation at HKD 2.54-2.54

Reuters
·
Jun 23

Lee's Pharmaceutical Announces Share Buyback Plan with HK$50 Million Cap

Stock News
·
Jun 16

Zhaoke Ophthalmology Buys Back 0.15% of Shares for HK$2.37 Million; Issued Share Capital Steady at 548.75 Million

Bulletin Express
·
Jun 16

Zhaoke Ophthalmology-B Executes Share Buyback, Spending Approximately HK$159,200

Stock News
·
Jun 16

Zhaoke Ophthalmology files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 16

Zhaoke Ophthalmology's Application for Children's Myopia Drug Accepted in Australia

MT Newswires Live
·
Jun 15

Zhaoke Ophthalmology’s Low-Dose Atropine Eye Drops Cleared for Evaluation by Australia’s TGA

Bulletin Express
·
Jun 15

Zhaoke Ophthalmology-B Receives Australian Regulatory Submission Acceptance for Atropine Eye Drop Evaluation

Stock News
·
Jun 15

Zhaoke Ophthalmology - Ophth-B Atropine Sulfate Eye Drops Application Accepted for Evaluation by Australia's Tga

THOMSON REUTERS
·
Jun 15

Zhaoke Ophthalmology-B Executes Share Buyback on June 11

Stock News
·
Jun 11